STRATÉGIES DE DOSAGE POUR CIBLER UN CANCER DE LA VESSIE POSITIF À L'EPCAM

• 收藏
• 分享

专利权人:

Viventia Bio Inc.

发明人:

HURLY, Stephen,MACDONALD, Glen

申请号：

EP16762631

公开号：

EP3268041A4

申请日:

2016.03.11

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present disclosure provides methods for treatment of bladder cancer. The methods include administering an immunoconjugate to a subject in a dosing regimen that includes an induction phase with twice weekly followed by once weekly dosing, and optionally a maintenance phase. The immunoconjugates useful in the methods provided include immunoconjugates having a binding protein that specifically binds to Ep-CAM and a toxin molecule.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/